住院患者普适性与目标性氯己定沐浴及鼻腔去定植的成本效果分析
该决策分析模型基于ABATE感染试验的模拟队列(529 000例成人入院),比较标准诊疗(SOC)、普适性去定植(UD)和目标性去定植(TD,仅对携带医疗装置者)三种策略下医院起病菌血症/真菌血症(HOB)的发生频率与成本。结果显示SOC效果最差且成本最高;TD成本最低;UD的HOB事件最少。从支付方和医院视角,TD均为具成本效果的策略;与TD相比,UD每避免1例HOB的增量成本效果比分别为119 700美元(支付方)和126 600美元(医院)。在携带医疗装置患者比例较高、去定植对装置患者HOB降幅更大或TD依从性较低等场景下,UD可能更优。
要点
- 在普通内外科病房模拟队列中,标准诊疗(SOC)效果最差且成本最高,目标性去定植(TD)成本最低,普适性去定植(UD)的HOB事件最少。
- 从支付方和医院视角,TD均为具成本效果的策略;与TD相比,UD每避免1例HOB的增量成本效果比分别为119 700美元(支付方)和126 600美元(医院)。
- 支付方对每避免1例HOB的支付意愿阈值为25 000美元,医院为10 000美元。
- 在携带医疗装置患者比例较高、去定植对装置患者HOB降幅更大或TD依从性较低的场景下,UD可能更优。
- 模拟队列基于ABATE试验人群:529 000例成人入院,平均(SD)年龄63(18)岁,54%女性,13%携带中心静脉导管、中线导管或腰大池引流。
适用人群与场景
- 模拟队列代表ABATE感染试验人群,为美国500 000例以上的集群随机试验参与者,模型纳入529 000例成人入院。
- 场景为普通内科和外科病房(非重症监护病房)。
诊断标准与关键阈值
- 支付方对每避免1例HOB的支付意愿阈值为25 000美元,医院为10 000美元。
处置流程与药物剂量
- 目标性去定植(TD):仅对携带医疗装置(中心静脉导管、中线导管和腰大池引流)的患者实施去定植。
- 普适性去定植(UD):对所有患者实施细菌去定植(氯己定沐浴及鼻腔去定植)。
- 标准诊疗(SOC):作为对照策略。
研究设计与关键结果
- 研究类型:决策分析模型,构建于2021年6月1日至2024年5月31日,模拟SOC、UD和TD三种策略下HOB频率与成本。
- 模拟队列基于ABATE试验人群,纳入529 000例成人入院,平均(SD)年龄63(18)岁,54%女性,13%携带中心静脉导管、中线导管或腰大池引流。
- 基础病例分析中,SOC效果最差且成本最高;TD成本最低;UD的HOB事件最少。
- 从支付方和医院视角,TD均为具成本效果的策略。
- 与TD相比,UD每避免1例HOB的增量成本效果比为119 700美元(支付方视角)和126 600美元(医院视角)。
- 取决于支付意愿,在携带医疗装置患者比例较高、去定植对装置患者HOB降幅更大以及TD依从性较低的场景下,UD可能更优。
证据类型、等级与局限
- 证据类型:决策分析模型,参数来源于ABATE感染试验及其他文献。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在普通内外科病房,目标性去定植(仅对携带医疗装置者)在广泛场景下对医院系统和支付方决策者均具成本效果;普适性去定植在部分场景(如许多患者携带医疗装置的特定病房,或难以实施目标性方案时)具成本效果。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The ABATE Infection trial investigated the effects of universal bacterial decolonization with chlorhexidine for patients in non-intensive care unit settings to reduce hospital-onset bacteremia and fungemia (HOB) events. Among patients with medical devices (central venous catheters, midline catheters, and lumbar drains), universal decolonization (UD) resulted in a significant and meaningful reduction in bacteremia compared with the standard of care (SOC), but cost-effectiveness is unclear.
OBJECTIVE: To examine the cost-effectiveness of universal and targeted bathing strategies compared with SOC in general medical and surgical units.
DESIGN, SETTING, AND PARTICIPANTS: A decision analytic model was constructed from June 1, 2021, to May 31, 2024, to simulate the frequency of HOB and costs under 3 strategies: SOC, UD, and targeted decolonization (TD). The model included a simulated cohort representative of the cluster-randomized ABATE Infection trial, which involved more than 500 000 participants across the US.
MAIN OUTCOMES AND MEASURES: In TD, decolonization was administered for patients with medical devices only. Upstream costs of bathing and downstream costs of HOB, under payer and hospital perspectives were included. Parameters were informed by the ABATE Infection Trial and additional literature. Willingness-to-pay per HOB prevented was adopted as $25 000 for payers and $10 000 for hospitals. Sensitivity analyses were tailored to populations with different characteristics.
RESULTS: The simulated cohort, based on the population from the ABATE trial, included 529 000 adult admissions with a mean (SD) age of 63 (18) years, 54% female, and 13% with a central venous catheter, midline catheter, or lumbar drain. In the base case, the SOC was least effective and most costly. Targeted decolonization was least costly and UD resulted in the fewest HOB events. Targeted decolonization was the cost-effective strategy from payer and hospital perspectives. Compared with TD, UD had an incremental cost-effectiveness ratio of $119 700 per HOB averted from the payer perspective, and $126 600 per HOB averted from the hospital perspective. Depending on willingness-to-pay, UD may be preferred in scenarios with a higher proportion of patients with medical devices, greater reductions in HOB from decolonizing in those with devices, and lower adherence under TD.
CONCLUSIONS AND RELEVANCE: In this decision analytic model studying universal and targeted bathing, TD was cost-effective under a broad range of scenarios for both hospital system and payer decision-makers. Universal decolonization was cost-effective in some scenarios, such as in specific units where many patients have medical devices or if it were difficult to implement a targeted approach.
参考来源
- James LP, Stout NK, Avery TR, et al. Universal vs Targeted Chlorhexidine Bathing and Nasal Decolonization in Hospitalized Patients. JAMA Netw Open. 2025. PMID: 40063027. doi:10.1001/jamanetworkopen.2025.0341
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。